We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2.26B
AUM Growth
+$299M
Cap. Flow
+$214M
Cap. Flow %
9.45%
Top 10 Hldgs %
6.6%
Holding
1,916
New
614
Increased
388
Reduced
316
Closed
591

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$16.7M
2
NFLX icon
Netflix
NFLX
+$14.1M
3
USB icon
US Bancorp
USB
+$12.4M
4
GE icon
GE Aerospace
GE
+$11.7M
5
CHTR icon
Charter Communications
CHTR
+$11.4M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$23M
2
ABBV icon
AbbVie
ABBV
+$18.8M
3
INTU icon
Intuit
INTU
+$13.1M
4
TXN icon
Texas Instruments
TXN
+$12.6M
5
BKNG icon
Booking.com
BKNG
+$10.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.57%
2 Industrials 13.56%
3 Technology 13.35%
4 Healthcare 13.31%
5 Financials 12.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SITO
1276
DELISTED
SITO MOBILE, LTD
SITO
$75K ﹤0.01%
+11,242
New +$79.1K
CRHM
1277
DELISTED
CRH Medical Corporation
CRHM
$74K ﹤0.01%
28,063
+3,560
+15% +$7.94K
TLRA
1278
DELISTED
Telaria, Inc.
TLRA
$73K ﹤0.01%
+18,285
New +$77.7K
CAMT icon
1279
Camtek
CAMT
$7.07B
$71K ﹤0.01%
12,561
-40,800
-76% -$236K
CTSO icon
1280
Cytosorbents Corp
CTSO
$22.6M
$69K ﹤0.01%
+10,647
New +$67.7K
CCXI
1281
DELISTED
ChemoCentryx, Inc.
CCXI
$67K ﹤0.01%
+11,297
New +$77.5K
ELGX
1282
DELISTED
Endologix Inc
ELGX
$66K ﹤0.01%
1,240
-15,979
-93% -$844K
ARMP icon
1283
Armata Pharmaceuticals
ARMP
$189M
$65K ﹤0.01%
4,651
+424
+10% +$6.26K
BCLI
1284
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$65K ﹤0.01%
1,113
+320
+40% +$19.1K
LRMR icon
1285
Larimar Therapeutics
LRMR
$398M
$65K ﹤0.01%
1,179
+155
+15% +$6.99K
AT
1286
DELISTED
Atlantic Power Corporation
AT
$65K ﹤0.01%
27,924
+16,646
+148% +$40.8K
ROX
1287
DELISTED
Castle Brands, Inc.
ROX
$64K ﹤0.01%
52,561
-91,843
-64% -$114K
KEYW
1288
DELISTED
The KEYW Holding Corporation
KEYW
$64K ﹤0.01%
+11,070
New +$69.3K
ABCD
1289
DELISTED
Cambium Learning Group, Inc.
ABCD
$63K ﹤0.01%
+11,130
New +$66.6K
WLB
1290
DELISTED
Westmoreland Coal Company
WLB
$62K ﹤0.01%
+51,278
New +$88.2K
ANTH
1291
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$58K ﹤0.01%
+35,300
New +$60.7K
CORV
1292
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$54K ﹤0.01%
34,872
+18,154
+109% +$29.2K
ARTX
1293
DELISTED
Arotech Corporation
ARTX
$52K ﹤0.01%
14,700
+2,700
+23% +$10.4K
SNMX
1294
DELISTED
Senomyx, Inc.
SNMX
$52K ﹤0.01%
+40,358
New +$45.7K
TPST icon
1295
Tempest Therapeutics
TPST
$14.9M
$51K ﹤0.01%
13
-10
-43% -$42K
FWP
1296
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$51K ﹤0.01%
+2,005
New +$70.1K
GNMX
1297
DELISTED
Aevi Genomic Medicine Inc
GNMX
$50K ﹤0.01%
41,879
-32,764
-44% -$44.7K
SRGA
1298
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$48K ﹤0.01%
+392
New +$53.8K
STRR
1299
DELISTED
Star Equity Holdings
STRR
$40K ﹤0.01%
+315
New +$38K
WTT
1300
DELISTED
Wireless Telecom Group, Inc.
WTT
$38K ﹤0.01%
+15,799
New +$31K
50 51
52
53 54

Similar funds

MA
MANA Advisors New York $3.06M AUM 7.13% 1-Year Est. Return
FFIM
Founders Fund III Management San Francisco, California $435K AUM
LC
Lunia Capital Dallas, Texas $4.49M AUM 42.82% 1-Year Est. Return
YEPV
Yorktown Energy Partners VI New York $6.21M AUM 74.4% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM

A.R.T. Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, A.R.T. Advisors held 1,916 positions worth $2.26B, up 15% from $1.96B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

A.R.T. Advisors deployed $214M of net new capital in Q4 2017, opening 614 new positions and adding to 388 existing holdings. Its largest new stake was IBM: 114,615 shares worth $16.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was AbbVie, an estimated $18.8M trimmed.

  • A.R.T. Advisors's largest Q4 2017 buy was IBM: 114,615 shares worth $16.8M.
  • A.R.T. Advisors added most to Netflix in Q4 2017, an estimated $14.1M increase.
  • A.R.T. Advisors's biggest Q4 2017 reduction was AbbVie, cutting an estimated $18.8M.
  • A.R.T. Advisors fully exited Celgene Corp in Q4 2017, selling an estimated $23M.
  • A.R.T. Advisors's ten largest holdings make up 6.6% of its $2.26B portfolio in Q4 2017.
  • A.R.T. Advisors opened 614 new positions and closed 591 in Q4 2017.
  • A.R.T. Advisors's portfolio value rose 15% quarter-over-quarter to $2.26B.

Based on A.R.T. Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.